Fig. 6From: Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinomaProtein–Protein interaction network among the causal proteins and current medication targets for LUAD. Red circles represented plasma proteins (FLT1 and NTM). Orange solid circles depicted current LUAD medication targets associated with potential proteins, while yellow solid circles represented current LUAD medication targets without such associations. The size of the circle indicated the number of interacting proteins. LUAD: lung adenocarcinomaBack to article page